Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colonic Neoplasms 3Breast Neoplasms 3Motor Activity 2Leiomyoma 2Warts 1Stomach Neoplasms 1Psychological Well-Being 1Psoriasis 1Prostatic Neoplasms 1Osteoporosis 1Osteoarthritis 1Obesity 1Nasopharyngeal Neoplasms 1Lung Neoplasms 1Inflammation 1Helicobacter Infections 1Esophageal Neoplasms 1Colorectal Neoplasms 1Chemotherapy-Related Cognitive Impairment 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1Autoimmune Diseases 1Arthritis, Rheumatoid 1

Interventions

Cisplatin 7Gemcitabine 6pembrolizumab 4Radiotherapy, Intensity-Modulated 4toripalimab 2Bevacizumab 2tocilizumab 1tislelizumab 1spartalizumab 1penpulimab 1atezolizumab 1Vitamin D 1Tablets 1Surveys and Questionnaires 1Phantoms, Imaging 1Oral Hygiene 1Observation 1Magnetic Resonance Spectroscopy 1Immunotherapy 1Immunohistochemistry 1Immunoglobulin G 1Fluorouracil 1Disulfides 1Dexamethasone 1Chemoradiotherapy 1Cetuximab 1Carboplatin 1Capecitabine 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Neoplasms × Vitamin D × 1 year × Clear all
NCT07042711 2025-06-29

Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients

Indonesia University

Phase NA Active not recruiting
300 enrolled
Head & Neck

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡